Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome

@article{Ford2018SystematicRW,
  title={Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome},
  author={Alexander Charles Ford and Lucinda A. Harris and Brian E. Lacy and Eamonn M M Quigley and Paul Moayyedi},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2018},
  volume={48},
  pages={1044 - 1060}
}
Irritable bowel syndrome (IBS) is a chronic functional bowel disorder. Disturbances in the gastrointestinal microbiome may be involved in its aetiology. 

Systematic review with meta‐analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

TLDR
Faecal microbiota transplantation is a highly effective treatment against recurrent Clostridioides difficile infection in randomised controlled trials (RCTs), and may be beneficial in ulcerative colitis, however, its efficacy in IBS is uncertain.

This is a repository copy of Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

TLDR
The primary outcome is to define cure following duration of follow-up and proportion of female patients is to be controlled for.

Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

TLDR
Irritable bowel syndrome (IBS) has been associated with microbial dysbiosis, and the role of gut bacteria in IBS is still poorly understood.

Gut fungal dysbiosis and altered bacterial‐fungal interaction in patients with diarrhea‐predominant irritable bowel syndrome: An explorative study

  • Gaichao HongYing Li X. Hou
  • Medicine
    Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2020
TLDR
In order to explore causal relationship between IBS and gut mycobiome, and use gut fungi to diagnose or even treat IBS, further characterization of it in IBS is required.

How effective are antibiotics for the treatment of irritable bowel syndrome?

TLDR
A person diagnosed with irritable bowel syndrome is likely to have a poorer quality of life than a person without IBS, particularly if they have a history of abusing alcohol or drugs.

Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome

TLDR
Overall, probiotics significantly improved global IBS symptoms compared to placebos, with significant heterogeneity between studies, and this remained apparent in both single- and multi-strain probiotic interventions as well as synbiotic formulations.

Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome

TLDR
A detailed review of the various pathophysiologic mechanisms of action of probiotics, prebiotics, and synbiotics via multidisciplinary domains involving the gastroenterology, immunology, and neurology in mitigating the symptoms of IBS.

Low FODMAP Diet and Probiotics in Irritable Bowel Syndrome: A Systematic Review With Network Meta-analysis

TLDR
Lactobacillus was the most effective component for the relief of IBS symptoms; Bifidobacterium and Bacillus were possibly effective and need further verification.

Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials.

TLDR
Prebiotics do not improve gastrointestinal symptoms or QoL in patients with IBS or other FBDs, but they do increase bifidobacteria.
...

References

SHOWING 1-10 OF 110 REFERENCES

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota

TLDR
A small number of patients diagnosed with irritable bowel syndrome with a history of diarrhoea or constipation are treated with probiotics, a type of probiotic, which can be beneficial in the absence of bowel problems.

Clinical trial: the effects of a trans‐galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

TLDR
This data indicates that modulation of gut microflora‐mucosal interactions may be involved in the pathogenesis of irritable bowel syndrome and may have an important role in selecting patients suitable for IBS.

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double‐blind placebo‐controlled study

TLDR
This data indicates that using probiotics to treat irritable bowel syndrome with a low dose increases the likelihood that the drug will be effective in the long term.

Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double‐blind, controlled study

TLDR
This study highlights the need to understand more fully the mechanism behind the immune response to probiotic bacteria in order to assess the importance of these bacteria in relieving constipation.

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6‐month intervention

TLDR
The presence of probiotics inIrritable bowel syndrome is a gastrointestinal disorder of unknown aetiology and the effect of Probiotics in this syndrome remains unclear.

Randomised clinical trial: a liquid multi‐strain probiotic vs. placebo in the irritable bowel syndrome – a 12 week double‐blind study

The importance of interactions between the host and gut microbiota in the pathogenesis of irritable bowel syndrome (IBS) is becoming increasingly apparent. Probiotics offer a potential new treatment

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

Abstract  Aim:  To evaluate the effects of a combination probiotic on symptoms and colonic transit in patients with irritable bowel syndrome (IBS) and significant bloating.

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea‐predominant irritable bowel syndrome

TLDR
The intestinal permeability is increased in patients with diarrhoea‐predominant irritable bowel syndrome (D‐IBS) and this increased permeability increases the likelihood that the patient will have diarrhea and/or constipation.

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome

Aim : To investigate the effects of a probiotic formulation, VSL#3, on gastrointestinal transit and symptoms of patients with Rome II irritable bowel syndrome with predominant diarrhoea.
...